跳至主要内容
临床试验/NCT00807430
NCT00807430终止不适用

A Single Centre, Randomised, Clinical Placebo Controlled Study of the Optimal Treatment and Long-term Effect of FES on Bruxism

Medotech A/S2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2009年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
48
试验地点
2
主要终点
Primary outcome is to reduce the EMG activity per hour per night

研究概览

简要总结

To investigate the effect of the treatment with Grindcare® on the muscles- and jaw symptoms and at the jaw muscle activity during sleep.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed and dated ICF
  • 18 years or older
  • Fulfill the RDC-criteria for myofascial TMD diagnose (group 1a or 1b)
  • Average pain more that 3 on a Visual Analog scale (VAS) in the baseline period

排除标准

  • Contraindication of concommitant diseases for the study judged by investigator
  • Daily use of pain medication, e.g. prophylaxis against migraine or headache.
  • Patients who are using occlusal splints in the treatment period.

结局指标

主要结局

Primary outcome is to reduce the EMG activity per hour per night

时间窗: 10 weeks after start of treatment

次要结局

  • Secondary outcome is to evaluate long-term effect of FES om EMG activity(after end of treatment with FES)

研究者

发起方
Medotech A/S
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验